Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Liu, Liang, Guozhen Yuan, Zaohuo Cheng, Guofu Zhang, Xiaowei Liu, and Huifang Zhang. "Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients." PLoS One 8, no. 9 (2013): e75259. |
|
Robinson, Sarah B., J. Andrew Hardaway, Shannon L. Hardie, Jane Wright, Ryan M. Glynn, Daniel P. Bermingham, Qiao Han, Sarah M. Sturgeon, Phyllis Freeman, and Randy D. Blakely. "Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization." Molecular and Cellular Neuroscience 78 (2017): 41-51. |
|
Soares?Weiser, Karla, Nicola Maayan, Hanna Bergman, Clare Davenport, Amanda J. Kirkham, Sarah Grabowski, and Clive E. Adams. "First rank symptoms for schizophrenia." Cochrane Database of Systematic Reviews 1 (2015). |
|
Zhang, Qinting, Wu Hong, Haozhe Li, Fanglan Peng, Fan Wang, Ningning Li, Hui Xiang et al. "Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression." International journal of psychophysiology 114 (2017): 9-15. |
|
Areal, Lorena Bianchine, Alice Laschuk Herlinger, Fabrício Souza Pelição, Cristina Martins-Silva, and Rita Gomes Wanderley Pires. "Crack cocaine inhalation induces schizophrenia-like symptoms and molecular alterations in mice prefrontal cortex." Journal of psychiatric research 91 (2017): 57-63. |
|
Moore, Bret A., Debbi A. Morrissette, Jonathan M. Meyer, and Stephen M. Stahl. "Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing." BJPsych bulletin 41, no. 3 (2017): 164-168. |
|
Garcia-Alvarez, Leticia, Maria Paz Garcia-Portilla, Leticia Gonzalez-Blanco, Pilar Alejandra Saiz Martinez, Lorena de la Fuente-Tomas, Isabel Menendez-Miranda, Celso Iglesias, and Julio Bobes. "Differential blood-based biomarkers of psychopathological dimensions of schizophrenia." Revista de Psiquiatría y Salud Mental (English Edition) 9, no. 4 (2016): 219-227. |
|
Lin, Bochao D., Anne Alkema, Triinu Peters, Janneke Zinkstok, Lars Libuda, Johannes Hebebrand, Jochen Antel et al. "Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study." International journal of epidemiology 48, no. 5 (2019): 1505-1514. |
|
Bhati, Mahendra T. "Defining psychosis: the evolution of DSM-5 schizophrenia spectrum disorders." Current psychiatry reports 15, no. 11 (2013): 409. |
|
MP O’Tuathaigh, Colm, Lieve Desbonnet, Peter Lee, and John L Waddington. "Catechol-O-methyl transferase as a drug target for schizophrenia." CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 11, no. 3 (2012): 282-291. |
|
Schultze-Lutter, Frauke, Chantal Michel, Stephan Ruhrmann, and Benno G. Schimmelmann. "Prevalence and clinical significance of DSM-5–attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study." Schizophrenia bulletin 40, no. 6 (2014): 1499-1508. |
|
Keinänen, Jaakko, Outi Mantere, Niina Markkula, Krista Partti, Jonna Perälä, Samuli I. Saarni, Tommi Härkänen, and Jaana Suvisaari. "Mortality in people with psychotic disorders in Finland: a population-based 13-year follow-up study." Schizophrenia research 192 (2018): 113-118. |
|
Tahir, Rana A., and Sheikh Arslan Sehgal. "Pharmacoinformatics and molecular docking studies reveal potential novel compounds against schizophrenia by target SYN II." Combinatorial chemistry & high throughput screening 21, no. 3 (2018): 175-181. |
|
Yang, Genevieve J., John D. Murray, Xiao-Jing Wang, David C. Glahn, Godfrey D. Pearlson, Grega Repovs, John H. Krystal, and Alan Anticevic. "Functional hierarchy underlies preferential connectivity disturbances in schizophrenia." Proceedings of the National Academy of Sciences 113, no. 2 (2016): E219-E228. |
|
Çakici, Nuray, Mariska Bot, Femke Lamers, Thomas Janssen, Peter J. van der Spek, Lieuwe de Haan, Sabine Bahn, Brenda WJH Penninx, and Nico JM van Beveren. "Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: a cross-disorder proteomics analysis." European Neuropsychopharmacology 29, no. 7 (2019): 835-846. |
|
Gil-Ad, Irit, Moshe Portnoy, Igor Tarasenko, Miri Bidder, Maria Kramer, Michal Taler, and Abraham Weizman. "A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia." European Neuropsychopharmacology 24, no. 3 (2014): 425-436. |
|
Lozupone, Madia, Maddalena La Montagna, Francesca D’Urso, Antonio Daniele, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Antonello Bellomo, and Francesco Panza. "The role of biomarkers in psychiatry." Reviews on biomarker studies in psychiatric and neurodegenerative disorders (2019): 135-162. |
|
Stahl, Stephen M., and Debbi A. Morrissette. "Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy?." In Polypharmacy in Psychiatry Practice, Volume I, pp. 107-125. Springer, Dordrecht, 2013. |
|
Miller, Brian J., Carmen B. Parker, Mark H. Rapaport, Peter F. Buckley, and William V. McCall. "Insomnia and suicidal ideation in nonaffective psychosis." Sleep 42, no. 2 (2019): zsy215. |
|
Fond, Guillaume, F. Berna, M. Andrianarisoa, O. Godin, M. Leboyer, L. Brunel, B. Aouizerate et al. "Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort." European archives of psychiatry and clinical neuroscience 267, no. 5 (2017): 465-472. |
|